Toxicologic evaluation of FK 506.
Ohara
K
K
Toxicology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd, Osaka, Japan.
Billington
R
R
James
R W
RW
Dean
G A
GA
Nishiyama
M
M
Noguchi
H
H
D000284:Administration, Oral; D000818:Animals; D000900:Anti-Bacterial Agents / Q000633:toxicity*; D001786:Blood Glucose / Q000378:metabolism; D001806:Blood Urea Nitrogen; D004285:Dogs; D007166:Immunosuppressive Agents / Q000633:toxicity*; D007275:Injections, Intravenous; D007928:Lethal Dose 50; D010215:Papio; D051381:Rats; D011919:Rats, Inbred Strains; D016559:Tacrolimus; D013997:Time Factors
D000900:Anti-Bacterial Agents; D001786:Blood Glucose; D007166:Immunosuppressive Agents; D016559:Tacrolimus